Because of the difficulty encountered in previous studies in the accurate classification and counting of potential angioedema episodes, a special evaluation process for the determination of ...

Garadacimab (CSL-312) is under development for the treatment of hereditary angioedema (HAE), idiopathic pulmonary fibrosis (IPF) and interstitial lung diseases (ILD). It is administered through ...

The following is a summary of “Disposition of emergency department patients presenting with angiotensin-converting enzyme inhibitor-induced angioedema,” published in the January 2025 issue of ...